Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9600 posts found.

Targacept cuts over a third of its staff

October 10, 2012 Research and Development

Targacept is to make 38% of its staff redundant and cease laboratory operations by the end of the year as …
News
Astrazeneca image

AZ licences renal disease compound

October 9, 2012 Research and Development, Sales and Marketing Ardelyx, AstraZeneca, NHE3

AstraZeneca has signed an agreement giving it worldwide exclusive rights to California-based Ardelyx’s NHE3 inhibitor programme targeting liver and kidney …
News
roger_marc_12

Novasep announces changes at the top

October 9, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development Novasep, Patrick Glaser, Roger-Marc Nicoud, manufacturing

Novasep has announced the appointment of Roger-Marc Nicoud, founder and chief executive, as non-executive chairman of the Board. The manufacturing …
Appointment
Social media image

Digital Pharma: what should we talk about?

October 8, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Facebook, Pfizer, digital pharma, social media, twiiter

The received wisdom today among the ‘digirati’ is that the pharmaceutical industry must join in the online conversation, and to …
Feature
Zaltrap image

Sanofi’s Zaltrap data published

October 8, 2012 Research and Development, Sales and Marketing Erbitux, Sanofi, Stivarga, Zaltrap, avastin

Detailed data from the Phase III trial of Sanofi’s newly-licenced anti-VEGF cancer drug Zaltrap, co-marketed with Regeneron, has been published. …
News
jim_chiltern

Chiltern announces new chief executive

October 8, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Jim Esinhart, chiltern

Contract research organisation Chiltern International has announced a successor to chief executive Glenn Kerkhof, who is stepping down to be …
Appointment
screen_shot_2012-10-05_at_09

Appointments and moves at the BIA

October 5, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, BioIndustry Association

The BioIndustry Association (BIA) has appointed Harren Jhoti and Will West to its Board of directors at its Annual General …
Appointment
114053815_tovey_341562c

GW Pharmaceuticals hires chief operating officer

October 4, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Chris Tovey, GW Pharmaceuticals

GW Pharmaceuticals has announced the appointment of Christopher John Tovey to the newly created position of chief operating officer. Tovey, …
Appointment
dame_christine_beasley_282x212

Non-executive directors of NHS Trust appointed

October 3, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Christine Beasley, NHS, Sarah Harkness

Christine Beasley and Sarah Harkness have been confirmed as non-executive directors of the NHS Trust Development Authority.  Ms Beasley (pictured) …
Appointment
Bayer image

Bayer signs endometriosis pact

October 3, 2012 Research and Development, Sales and Marketing Bayer, Evotec, endometriosis

Bayer HealthCare and Evotec have signed a five-year deal to look for three novel drugs to treat women with endometriosis. …
News
Roche and GSK image

Is it really safety first?

October 2, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Les Rose, Roche

The idea of ensuring that drugs are adequately safe is not very old. Legislation that covers drug safety to the …
Feature

Catalent and CTC Partner to Help Korean Pharma Take Their Products to Western Markets

October 2, 2012 Research and Development

Somerset, NJ, September 13, 2012 – Catalent Pharma Solutions and CTC Bio have entered into a collaboration to provide optimal …
News
Press release
votrient image

Survival boost for Votrient in mRCC

October 2, 2012 Research and Development, Sales and Marketing GSK, Nexavar, Pfizer, Sutent, Votrient

GlaxoSmithKline’s renal cell carcinoma drug Votrient has proved itself non-inferior to a bitter rival, Pfizer’s Sutent, in terms of progression-free …
News

Cmed Clinical Services Strengthens Management Team

October 1, 2012 Research and Development

HORSHAM, UK — September 13, 2012 – Cmed Clinical Services has today announced three new appointments to its management team …
News
Press release
yervoy image

BMS highlights Yervoy survival data

October 1, 2012 Research and Development, Sales and Marketing BMS, Roche, Yervoy, Zelboraf

Bristol-Myers Squibb’s melanoma drug Yervoy helps patients survive for longer than if they are receiving standard chemotherapy alone, according to …
News
The Gateway to Local Adoption Series

Latest content

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026

eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer

March 6, 2026